BMS 100 mg 3623 (Reyataz 100 mg)
Generic Name: atazanavir
Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 100 mg 3623
Reyataz
- Generic Name:
- atazanavir
- Imprint:
- BMS 100 mg 3623
- Strength:
- 100 mg
- Color:
- Blue & White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-3623
- Inactive Ingredients:
-
- crospovidone
- lactose monohydrate
- magnesium stearate
- gelatin
- FD&C Blue No. 2
- titanium dioxide
- ferric oxide red
- ferric oxide yellow
- isopropyl alcohol
- ammonia
- propylene glycol
- butyl alcohol
- alcohol
- ferrosoferric oxide
- shellac
Note: Inactive ingredients may vary.
More about Reyataz (atazanavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Generic Availability
- Drug class: protease inhibitors
- FDA Alerts (3)
Consumer resources
- Reyataz
- Reyataz (Atazanavir Capsules)
- Reyataz (Atazanavir Powder for Oral Suspension)
- Reyataz (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
